ATOSSA THERAPEUTICS, INC. (ATOS)
Nasdaq: ATOS · CIK 0001488039 · United States
Every official ATOSSA THERAPEUTICS, INC. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ATOS filings
ATOSSA THERAPEUTICS, INC. documents
- ATOSSA THERAPEUTICS, INC. 10-K 2026ATOS 10-K 2026: annual report for fiscal 2026
- ATOSSA THERAPEUTICS, INC. 10-K 2025ATOS 10-K 2025: annual report for fiscal 2025
- ATOSSA THERAPEUTICS, INC. 10-K 2024ATOS 10-K 2024: annual report for fiscal 2024
- ATOSSA THERAPEUTICS, INC. 10-K 2023ATOS 10-K 2023: annual report for fiscal 2023
- ATOSSA THERAPEUTICS, INC. 10-K 2022ATOS 10-K 2022: annual report for fiscal 2022
- ATOSSA THERAPEUTICS, INC. 10-Q 2026ATOS 10-Q 2026: quarterly report for fiscal 2026
- ATOSSA THERAPEUTICS, INC. 10-Q 2025ATOS 10-Q 2025: quarterly report for fiscal 2025
- ATOSSA THERAPEUTICS, INC. 10-Q 2024ATOS 10-Q 2024: quarterly report for fiscal 2024
- ATOSSA THERAPEUTICS, INC. 10-Q 2023ATOS 10-Q 2023: quarterly report for fiscal 2023
- ATOSSA THERAPEUTICS, INC. 10-Q 2022ATOS 10-Q 2022: quarterly report for fiscal 2022
- ATOSSA THERAPEUTICS, INC. 8-K 2026ATOS 8-K 2026: current report for fiscal 2026
- ATOSSA THERAPEUTICS, INC. 8-K 2025ATOS 8-K 2025: current report for fiscal 2025
- ATOSSA THERAPEUTICS, INC. 8-K 2024ATOS 8-K 2024: current report for fiscal 2024
- ATOSSA THERAPEUTICS, INC. 8-K 2023ATOS 8-K 2023: current report for fiscal 2023
- ATOSSA THERAPEUTICS, INC. 8-K 2022ATOS 8-K 2022: current report for fiscal 2022
- ATOSSA THERAPEUTICS, INC. DEF 14A 2026ATOS DEF 14A 2026: proxy statement for fiscal 2026
- ATOSSA THERAPEUTICS, INC. DEF 14A 2025ATOS DEF 14A 2025: proxy statement for fiscal 2025
- ATOSSA THERAPEUTICS, INC. DEF 14A 2024ATOS DEF 14A 2024: proxy statement for fiscal 2024
- ATOSSA THERAPEUTICS, INC. DEF 14A 2023ATOS DEF 14A 2023: proxy statement for fiscal 2023
- ATOSSA THERAPEUTICS, INC. DEF 14A 2022ATOS DEF 14A 2022: proxy statement for fiscal 2022
- ATOSSA THERAPEUTICS, INC. Form 4 2026ATOS Form 4 2026: insider trading filing for fiscal 2026
- ATOSSA THERAPEUTICS, INC. Form 4 2025ATOS Form 4 2025: insider trading filing for fiscal 2025
- ATOSSA THERAPEUTICS, INC. Form 4 2024ATOS Form 4 2024: insider trading filing for fiscal 2024
- ATOSSA THERAPEUTICS, INC. Form 4 2023ATOS Form 4 2023: insider trading filing for fiscal 2023
- ATOSSA THERAPEUTICS, INC. Form 4 2022ATOS Form 4 2022: insider trading filing for fiscal 2022
- ATOSSA THERAPEUTICS, INC. S-1 2026ATOS S-1 2026: registration statement for fiscal 2026
- ATOSSA THERAPEUTICS, INC. S-1 2025ATOS S-1 2025: registration statement for fiscal 2025
- ATOSSA THERAPEUTICS, INC. S-1 2024ATOS S-1 2024: registration statement for fiscal 2024
- ATOSSA THERAPEUTICS, INC. S-1 2023ATOS S-1 2023: registration statement for fiscal 2023
- ATOSSA THERAPEUTICS, INC. S-1 2022ATOS S-1 2022: registration statement for fiscal 2022
- ATOSSA THERAPEUTICS, INC. 13F 2026ATOS 13F 2026: institutional holdings for fiscal 2026
- ATOSSA THERAPEUTICS, INC. 13F 2025ATOS 13F 2025: institutional holdings for fiscal 2025
- ATOSSA THERAPEUTICS, INC. 13F 2024ATOS 13F 2024: institutional holdings for fiscal 2024
- ATOSSA THERAPEUTICS, INC. 13F 2023ATOS 13F 2023: institutional holdings for fiscal 2023
- ATOSSA THERAPEUTICS, INC. 13F 2022ATOS 13F 2022: institutional holdings for fiscal 2022
More companies